Home › Cytomegalovirus Infections › Wisconsin
Cytomegalovirus Infections clinical trials in Wisconsin
3 studies for Cytomegalovirus Infections are looking for participants at sites in Wisconsin.
Phase 3 Randomized Trial for Refractory ADV or CMV Infection With Family Matched CTLs and Standard of Care (SOC) vs SOC Alone
- Medical College of Wisconsin, Milwaukee
RecruitingPhase 3
1 Day – 30 Years · All sexes · Updated Sep 11, 2026 · NCT07225972Letermovir (Prevymis) for CMV in Kidney and Pancreas Transplant Recipients
- UW Hospital and Clinics, Madison
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Jun 11, 2026 · NCT06407232Virus Specific Cytotoxic T-Lymphocytes (CTLs) for Refractory Cytomegalovirus (CMV)
- Medical College of Wisconsin/Children's Hospital of Wisconsin, Milwaukee
RecruitingPhase 2
1 Month – 79 Years · All sexes · Updated Aug 8, 2025 · NCT03266640From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.